Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK, the cost of Mounjaro as a private weight-loss treatment typically ranges from around £149 to £375 per month, depending on the dose and the provider you use — a range that widened significantly after Eli Lilly raised its UK list price in September 2025, with the highest-dose pen's list price rising from roughly £122 to around £330. These are private prescription figures; Mounjaro is a prescription-only medicine, so there is no legal route to it without a clinical assessment by a registered prescriber. What varies between providers (sometimes dramatically) is what that monthly figure actually covers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro comes in six strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg) and each sits at a different price point. Treatment starts at the lowest dose while your body adjusts, then typically increases in monthly steps as your prescriber decides. That means the figure you see quoted for, say, a 2.5 mg pen is not what most people pay long-term; the full Mounjaro price list by dose shows how costs shift across the titration schedule.
Since September 2025, Eli Lilly's UK list price increase has fed through to most private providers. Reported private prices now range roughly £149 at the lowest dose to around £375 at the highest, though individual providers set their own margins. If you want to understand what Mounjaro costs across the full range of doses and providers, treat any figure you see advertised as a starting point for a conversation, not a final number.
The Mounjaro overview page sets out how the medicine works and what the licensed titration schedule looks like, useful context before comparing prices across providers.
A headline price for Mounjaro sometimes covers the pen and nothing else. Many providers charge separately for the initial consultation, the prescription, follow-up reviews, and delivery. Some require a monthly subscription that auto-renews even if you want to pause. Some charge a fee for dose-increase reviews, which you will need if you move up the titration ladder.
That quiet pen sitting in the fridge door next to the milk represents a chain of clinical decisions, an eligibility check, an ID and weight verification, a prescriber sign-off, and ongoing monitoring. When those steps are priced separately, a low headline figure can end up costing more in practice than a higher all-in quote. The per-pen cost breakdown walks through exactly what you should expect each pen to include.
A question our prescribers hear most weeks is whether a cheaper quote from a lesser-known site is legitimate. Legitimacy starts with checking whether the pharmacy is registered on the GPhC register, our own registration number is 9012878, and you can verify it directly.
At nume, one price covers the consultation, the prescription, the treatment at your current dose, free next-working-day tracked DPD delivery, and seven-day aftercare. No subscription. No auto-renewal. Every repeat order goes back in front of a prescriber before it ships. We don't compete on being the lowest quote, and that's deliberate, a small saving per pen is not the right measure when you're taking a prescription medicine that requires ongoing clinical oversight.
Our clinical team reviews every consultation personally. If a dose increase is requested, we ask for evidence that the previous dose has been tolerated before approving it. That adds a step; it also adds safety. Current treatment pricing is shown on the weight-loss treatments page, we don't print per-pen figures here because they vary by dose and we'd rather you see the full picture in one place.
The MHRA has documented large-scale seizures of counterfeit weight-loss pens sold online, including fake tirzepatide pens manufactured illicitly in the UK and seized in Northampton in October 2025. Some fake pens have contained insulin. The common thread: prices far below market, sellers operating outside the regulated supply chain, and no genuine clinical assessment involved. The MHRA's Yellow Card scheme lets you report both suspected side effects and suspected illegal sellers.
NICE's appraisal of tirzepatide, TA1026, describes the clinical evidence base for this medicine, it's substantial, and it was built around closely monitored participants on a structured titration schedule. Replicating those outcomes in practice requires the same discipline: a prescriber who knows your history, dose reviews at the right intervals, and a supply chain you can verify. If you are currently on the second step of the titration schedule, our page on what the 5 mg dose costs and what that figure should include is a useful reference before you compare providers. The Mounjaro pricing guide covers what legitimate private providers should include as standard. Price is one input. It should not be the deciding one.
If you want to check your eligibility and understand exactly what treatment through nume would involve, speak to our prescribers, the consultation is free, with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.